Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wunderlich

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarrayMartin J Romeo, John Wunderlich, Lien Ngo, et al.
Cancer|September 15, 2010
Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesotheliomaSheelu Varghese, Zhaorong Chen, David L Bartlett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapyPaul F Robbins, Mark E Dudley, John Wunderlich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapyRussell C Langan, Peter A Prieto, Richard M Sherry, et al.
The Journal of Investigative Dermatology|April 18, 2014
Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formationTodd D Prickett, Brad J Zerlanko, Victoria K Hill, et al.
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Pigment Cell & Melanoma Research|May 9, 2009
Frequent mutations in the MITF pathway in melanomaJulia C Cronin, John Wunderlich, Stacie K Loftus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimensMark E Dudley, James C Yang, Richard Sherry, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarrayMartin J Romeo, John Wunderlich, Lien Ngo, et al.
Cancer|September 15, 2010
Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesotheliomaSheelu Varghese, Zhaorong Chen, David L Bartlett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapyPaul F Robbins, Mark E Dudley, John Wunderlich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapyRussell C Langan, Peter A Prieto, Richard M Sherry, et al.
The Journal of Investigative Dermatology|April 18, 2014
Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formationTodd D Prickett, Brad J Zerlanko, Victoria K Hill, et al.
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Pigment Cell & Melanoma Research|May 9, 2009
Frequent mutations in the MITF pathway in melanomaJulia C Cronin, John Wunderlich, Stacie K Loftus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimensMark E Dudley, James C Yang, Richard Sherry, et al.
Pageof 1